O	0	10	Diagnostic
O	11	19	Accuracy
O	20	22	of
O	23	33	Technology
O	33	34	-
O	34	39	based
B-Anatomy	40	43	Eye
O	44	48	Care
O	49	57	Services
O	57	58	:
O	59	62	The
O	63	73	Technology
O	73	74	-
O	74	79	based
B-Anatomy	80	83	Eye
O	84	88	Care
O	89	97	Services
O	98	105	Compare
O	106	111	Trial
O	112	116	Part
O	117	118	I
O	118	119	.

O	121	135	Ophthalmologic
O	136	148	telemedicine
O	149	152	has
O	153	156	the
O	157	164	ability
O	165	167	to
O	168	175	provide
B-Anatomy	176	179	eye
O	180	184	care
O	185	188	for
O	189	197	patients
O	198	206	remotely
O	206	207	,
O	208	211	and
O	212	216	many
O	217	226	countries
O	227	231	have
O	232	236	used
O	237	246	screening
O	247	251	tele
O	251	252	-
O	252	265	ophthalmology
O	266	274	programs
O	275	278	for
O	279	286	several
O	287	292	years
O	292	293	.

O	294	297	One
O	298	302	such
O	303	313	initiative
O	314	316	at
O	317	320	the
O	321	329	Veterans
O	330	337	Affairs
O	338	339	(
O	339	341	VA
O	341	342	)
O	343	353	Healthcare
O	354	360	System
O	361	363	is
O	364	374	Technology
O	374	375	-
O	375	380	based
B-Anatomy	381	384	Eye
O	385	389	Care
O	390	398	Services
O	399	400	(
O	400	404	TECS
O	404	405	)
O	405	406	.

O	407	410	The
O	411	415	TECS
O	416	424	services
O	425	428	are
O	429	436	located
O	437	439	in
O	440	447	primary
O	448	452	care
O	453	460	clinics
O	461	464	and
O	465	472	provide
O	473	478	basic
O	479	488	screening
B-Anatomy	489	492	eye
O	493	497	care
O	497	498	,
O	499	508	including
O	509	515	vision
O	515	516	,
O	517	527	refraction
O	527	528	,
O	529	532	and
B-Diagnostic_tool	533	540	retinal
I-Diagnostic_tool	541	552	photography
O	552	553	.

B-Anatomy	554	557	Eye
O	558	562	care
O	563	572	providers
O	573	574	(
O	575	576	"
O	577	584	readers
O	585	586	"
O	587	588	)
O	589	595	review
O	596	599	the
O	600	608	clinical
O	609	613	data
O	614	617	and
O	618	627	recommend
O	628	639	appropriate
O	640	646	follow
O	646	647	-
O	647	649	up
O	649	650	.

O	651	654	One
O	655	657	of
O	658	661	the
O	662	666	most
O	667	673	common
O	674	683	referrals
O	684	688	from
O	689	693	TECS
O	694	697	has
O	698	702	been
O	703	706	for
B-Disease	707	715	glaucoma
O	715	716	,
O	717	720	and
O	721	725	this
O	726	731	study
O	732	735	was
O	736	743	powered
O	744	747	for
B-Disease	748	756	glaucoma
O	756	757	/
B-Disease	757	765	glaucoma
I-Disease	766	773	suspect
O	774	783	detection
O	783	784	.

O	785	788	The
O	789	796	current
O	797	802	study
O	803	806	was
O	807	817	undertaken
O	818	820	to
O	821	829	identify
O	830	837	aspects
O	838	840	of
O	841	844	the
O	845	853	protocol
O	854	858	that
O	859	864	could
O	865	867	be
O	868	875	refined
O	876	878	to
O	879	886	enhance
O	887	895	accuracy
O	895	896	.

O	897	908	Prospective
O	909	919	comparison
O	920	927	between
O	928	931	the
O	932	940	standard
O	941	945	TECS
O	946	954	protocol
O	955	961	versus
O	962	963	a
B-Diagnostic_tool	964	968	face
I-Diagnostic_tool	968	969	-
I-Diagnostic_tool	969	971	to
I-Diagnostic_tool	971	972	-
I-Diagnostic_tool	972	976	face
I-Diagnostic_tool	977	978	(
I-Diagnostic_tool	978	981	FTF
I-Diagnostic_tool	981	982	)
I-Diagnostic_tool	983	994	examination
O	995	997	on
O	998	1001	256
O	1002	1010	patients
O	1010	1011	,
O	1012	1015	all
O	1016	1018	of
O	1019	1023	whom
O	1024	1027	had
O	1028	1030	no
O	1031	1036	known
O	1037	1044	history
O	1045	1047	of
O	1048	1059	significant
B-Disease	1060	1066	ocular
I-Disease	1067	1074	disease
O	1074	1075	.

O	1076	1084	Patients
O	1085	1089	with
O	1090	1092	no
O	1093	1098	known
O	1099	1105	ocular
O	1106	1113	disease
O	1114	1117	who
O	1118	1122	were
O	1123	1132	scheduled
O	1133	1136	for
O	1137	1139	an
O	1140	1142	in
O	1142	1143	-
O	1143	1149	person
B-Anatomy	1150	1153	eye
O	1154	1165	appointment
O	1166	1168	at
O	1169	1172	the
O	1173	1180	Atlanta
O	1181	1183	VA
O	1183	1184	.

O	1185	1193	Patients
O	1194	1203	underwent
O	1204	1213	screening
O	1214	1221	through
O	1222	1225	the
O	1226	1230	TECS
O	1231	1239	protocol
O	1240	1243	and
O	1244	1252	received
O	1253	1255	an
B-Diagnostic_tool	1256	1259	FTF
I-Diagnostic_tool	1260	1271	examination
O	1272	1274	on
O	1275	1278	the
O	1279	1283	same
O	1284	1287	day
O	1288	1289	(
O	1289	1293	gold
O	1294	1302	standard
O	1302	1303	)
O	1303	1304	.

O	1305	1308	The
O	1309	1313	TECS
O	1314	1321	readers
O	1322	1326	were
O	1327	1333	masked
O	1334	1336	to
O	1337	1340	the
O	1341	1348	results
O	1349	1351	of
O	1352	1355	the
B-Diagnostic_tool	1356	1359	FTF
I-Diagnostic_tool	1360	1371	examination
O	1371	1372	.

O	1373	1380	Percent
O	1381	1390	agreement
O	1390	1391	,
O	1392	1397	kappa
O	1397	1398	,
O	1399	1410	sensitivity
O	1410	1411	,
O	1412	1415	and
O	1416	1427	specificity
O	1428	1432	were
O	1433	1443	calculated
O	1444	1447	for
O	1448	1451	the
O	1452	1456	TECS
O	1457	1464	readers
O	1464	1465	'
O	1466	1481	interpretations
O	1482	1488	versus
O	1489	1492	the
B-Diagnostic_tool	1493	1496	FTF
I-Diagnostic_tool	1497	1508	examination
O	1508	1509	.

O	1510	1513	The
O	1514	1518	TECS
O	1519	1526	readers
O	1527	1533	showed
O	1534	1545	substantial
O	1546	1555	agreement
O	1556	1559	for
B-Disease	1560	1568	cataract
O	1569	1570	(
O	1570	1571	κ
O	1572	1573	≥
O	1574	1575	0
O	1575	1576	.
O	1576	1578	71
O	1578	1579	)
O	1580	1583	and
B-Disease	1584	1592	diabetic
I-Disease	1593	1604	retinopathy
O	1605	1606	(
O	1606	1607	κ
O	1608	1609	≥
O	1610	1611	0
O	1611	1612	.
O	1612	1614	61
O	1614	1615	)
O	1616	1619	and
O	1620	1628	moderate
O	1629	1631	to
O	1632	1643	substantial
O	1644	1653	agreement
O	1654	1657	for
B-Disease	1658	1666	glaucoma
O	1666	1667	/
B-Disease	1667	1675	glaucoma
I-Disease	1676	1683	suspect
O	1684	1685	(
O	1685	1686	κ
O	1687	1688	≥
O	1689	1690	0
O	1690	1691	.
O	1691	1693	52
O	1693	1694	)
O	1695	1703	compared
O	1704	1708	with
O	1709	1711	an
B-Diagnostic_tool	1712	1715	FTF
I-Diagnostic_tool	1716	1727	examination
O	1727	1728	.

B-Disease	1729	1732	Age
I-Disease	1732	1733	-
I-Disease	1733	1740	related
I-Disease	1741	1748	macular
I-Disease	1749	1761	degeneration
O	1762	1763	(
B-Disease	1763	1766	AMD
O	1766	1767	)
O	1768	1774	showed
O	1775	1783	moderate
O	1784	1793	agreement
O	1794	1795	(
O	1795	1796	κ
O	1797	1798	≥
O	1799	1800	0
O	1800	1801	.
O	1801	1803	34
O	1803	1804	)
O	1804	1805	.

O	1806	1813	Percent
O	1814	1823	agreement
O	1824	1828	with
O	1829	1832	the
B-Diagnostic_tool	1833	1837	TECS
I-Diagnostic_tool	1838	1846	protocol
O	1847	1850	was
O	1851	1855	high
O	1856	1857	(
O	1857	1859	84
O	1859	1860	.
O	1860	1861	3
O	1861	1862	%
O	1862	1863	-
O	1863	1865	98
O	1865	1866	.
O	1866	1867	4
O	1867	1868	%
O	1868	1869	)
O	1870	1873	for
O	1874	1878	each
O	1879	1881	of
O	1882	1885	the
O	1886	1893	disease
O	1894	1904	categories
O	1904	1905	.

O	1906	1913	Overall
O	1914	1925	sensitivity
O	1926	1929	and
O	1930	1941	specificity
O	1942	1946	were
O	1947	1948	≥
O	1948	1950	75
O	1950	1951	%
O	1952	1955	and
O	1956	1957	≥
O	1957	1959	55
O	1959	1960	%
O	1960	1961	,
O	1962	1974	respectively
O	1974	1975	,
O	1976	1979	for
O	1980	1983	any
O	1984	1993	diagnosis
O	1994	2003	resulting
O	2004	2006	in
O	2007	2015	referral
O	2015	2016	.

O	2017	2022	Inter
O	2022	2023	-
O	2023	2029	reader
O	2030	2033	and
O	2034	2039	intra
O	2039	2040	-
O	2040	2046	reader
O	2047	2056	agreement
O	2057	2060	was
O	2061	2072	substantial
O	2073	2076	for
O	2077	2081	most
O	2082	2091	diagnoses
O	2092	2093	(
O	2093	2094	κ
O	2096	2097	>
O	2099	2100	0
O	2100	2101	.
O	2101	2103	61
O	2103	2104	)
O	2105	2109	with
O	2110	2117	percent
O	2118	2128	agreements
O	2129	2136	ranging
O	2137	2141	from
O	2142	2144	66
O	2144	2145	%
O	2146	2148	to
O	2149	2151	99
O	2151	2152	%
O	2152	2153	.

O	2154	2157	Our
O	2158	2165	results
O	2166	2174	indicate
O	2175	2179	that
O	2180	2183	the
O	2184	2192	standard
B-Diagnostic_tool	2193	2197	TECS
I-Diagnostic_tool	2198	2206	protocol
O	2207	2209	is
O	2210	2218	accurate
O	2219	2223	when
O	2224	2232	compared
O	2233	2237	with
O	2238	2240	an
B-Diagnostic_tool	2241	2244	FTF
I-Diagnostic_tool	2245	2256	examination
O	2257	2260	for
O	2261	2264	the
O	2265	2274	detection
O	2275	2277	of
O	2278	2284	common
B-Disease	2285	2288	eye
I-Disease	2289	2297	diseases
O	2297	2298	.

O	2299	2302	The
O	2303	2312	inclusion
O	2313	2315	of
O	2316	2326	additional
O	2327	2334	testing
O	2335	2339	such
O	2340	2342	as
B-Diagnostic_tool	2343	2346	OCT
O	2347	2352	could
O	2353	2360	further
O	2361	2368	enhance
O	2369	2379	diagnostic
O	2380	2390	capability
O	2390	2391	.
